Replies to post #3631 on Ecomike's Favorite stock picks and Stock DD topics

[Aquahoya]

$MILV Thank you for posting that update to the OTCMarkets homepage for MILV. Saw that they updated their bio page with the new owners of the ticker and the website: ndtpharma.com

I like that they are using the shorter URL. It's much cleaner than the longer bulky ones. I imagine they will make it so those URLs automatically push to the main website.

Only a matter of time before the hearing March 12, 2020 for termination.

[Solar_Express]

Headline: GNBT Generex Receives Contract from Four Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines

GNBT is Getting Seriously Interesting Turnaround OTC Biotech Company with lots of subs. Besides their turnaround and S1 (2 NASDAQ uplistings) the Corona thing just landed on their lap. Read on

Generex has Funding, Covad/19 Chinese Contract, Royalties, Recent Articles and WHO Recognition. The CHINESE SIGN A CONTRACT with GENEREX THIS IS HUGE when you sit back and realize the only thing holding this back is "what you tell me" This company is being looked at as an OTC Shell LOL. Its a lot more than people realize with many subs. This shell will burst onto the NASDAQ Times 2 Leading with NGIO. Fact: Covid/19 plays have been runners in recent days. You know what else I hope Generex can lead the way to make an effective vaccine. This is some serious sh"t.

LOOKS SOLID for NGIO: Our subsidiary NuGenerex Immuno-Oncology (NGIO) "Future NASDAQ Listing" has developed Ii-Key peptide vaccines against several potentially pandemic viruses, including bird flu, swine, flu, HIV, and a previous coronavirus, SARS. This wealth of experience has enabled us to develop a standardized protocol for rapid vaccine development, so we are positioned to respond in the event of a new, emerging pathogen. Our partners in China have recognized the power of our Ii-Key platform and have delivered this contract to establish a collaboration to combat the COVID-19 epidemic, and we are excited to begin the work.”

Worth Lot more than 80 cents worth. Fuzzy rapid numbers upward may come into play very soon.

GNBT Generex Receives Contract from Four Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154104505

[Solar_Express]

MILV Yeeesss Found a 2 Nice REITs insides buying they went on heavy sale last week NRZ CIM / Money Injected Great place to Park Money in a dt.

Many 10K 30K late today slaps lately.

They need to get the OTC straightened Out. Foremost Im sure you understand this probably better than myself.

Have you been on contact at all injecting any ideas or suggestions that they also have I-Hub's eyeballs and the MLIV Army lol.

Once the dust turns into silver that wound be sweet,

http://stockcharts.com/c-sc/sc?s=NRZ&p=D&st=2013-05-02&en=(today)&i=t36275682205&r=1368753670695

[RealDutch]

Cash $717M as per appraisal firm

Hey Mike, folks.

That's the title of my sticky on the HERB message board. And that's the sticky that got us some attention lately.

HERB has a $3M market cap and is trading at 2 friggin cents.
Mike will tell you that I am no fool. And I am not :-)

I was inviting some big whales over the weekend and since we ran into each other lately I thought, why not visit this message board.

The case,

1) Yes, they should be sitting on $700M+ in cash
2) 83% owned by the Gansu provincial government, so a CEO rip-off is not going to happen
3) It's a non-reporting Chinese pinky but I'm expecting either a merger with the sister company in Shanghai, a buyout or going private offer, or even a huge dividend if the state needs money due to Corona.

That is all. You just need a very small position for an exceptional ROI.

GL, and stay healthy :-)

[RealDutch]

No longer pursuing MVTG (Spectrum), eh?

Start-ups are a bitch. I know all about it....

[RealDutch]

MILV and HERB have roughly the same market cap.

Except HERB has a little more cash :-D

Each to their own ;-)

Caveat Emptor, whooooooo, my kinda stock :-)

Time for a one-two punch perhaps. In our favor.